A Functional Interleukin-1 Receptor Antagonist Polymorphism Influences Atherosclerosis Development The Interleukin-1.BETA.:Interleukin-1 Receptor Antagonist Balance in Atherosclerosis

Authors :: Ann Samnegård
Yuri Sheikine
Per Eriksson
Ken Jatta
Peder S. Olofsson
Mehran Ghaderi
Allan Sirsjö
Source :: Circulation Journal. 73:1531-1536
Publication Year :: 2009
Publisher :: Japanese Circulation Society, 2009.
Abstract: Background: Interleukin (JL)-I² plays a central role in inflammation and atherosclerosis, but levels of IL-1I², its natural antagonist, IL-1Ra, and their balance in human atherosclerotic lesions, a ...

Subjects :: medicine.medical_specialty
business.industry
Interleukin-1beta
Antagonist
Interleukin
Inflammation
General Medicine
medicine.disease
Coronary artery disease
Interleukin 1 receptor antagonist
Endocrinology
Immunity
Internal medicine
Immunology
medicine
medicine.symptom
Cardiology and Cardiovascular Medicine
business
Receptor

Tools